The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Intrinsic ADRB2 inhibition improves CAR-T cell therapy efficacy against prostate cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lorton, D., & Bellinger, D. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16035635 · Cited by 221
Research works printed but not linked: 51
- Harris, 2021, Current status of CAR T cell therapy for leukemias, Curr. Treat. Options Oncol., 22, 62, 10.1007/s11864-021-00859-8 · DOI
- Yong, 2017, CAR T-cell therapy of solid tumors, Immunol. Cell Biol., 95, 356, 10.1038/icb.2016.128 · DOI · Paper page
- Wagner, 2020, CAR T cell therapy for solid tumors: bright future or dark reality?, Mol. Ther., 28, 2320, 10.1016/j.ymthe.2020.09.015 · DOI · Paper page
- Farooq, 2023, β2-Adrenergic Receptor Mediated Inhibition of T Cell Function and Its Implications for CAR-T Cell Therapy, Int. J. Mol. Sci., 24, 10.3390/ijms241612837 · DOI
- Tarr, 2012, β-Adrenergic receptor mediated increases in activation and function of natural killer cells following repeated social disruption, Brain Behav. Immun., 26, 1226, 10.1016/j.bbi.2012.07.002 · DOI
- Nijhuis, 2014, Adrenergic β2 receptor activation stimulates anti-inflammatory properties of dendritic cells in vitro, PloS one, 9, 10.1371/journal.pone.0085086 · DOI
- Takenaka, 2016, Norepinephrine Controls Effector T Cell Differentiation through β2-Adrenergic Receptor–Mediated Inhibition of NF-κB and AP-1 in Dendritic Cells, J. Immun., 196, 637, 10.4049/jimmunol.1501206 · DOI
- Qiao, 2018, Adrenergic signaling: a targetable checkpoint limiting development of the antitumor immune response, J. Immun., 9, 164
- Qiao, 2019, β-Adrenergic signaling blocks murine CD8+ T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress, Cancer Immunol. Immuno., 68, 11, 10.1007/s00262-018-2243-8 · DOI · Paper page
- Ajmal, 2022, Isoprenaline and salbutamol inhibit pyroptosis and promote mitochondrial biogenesis in arthritic chondrocytes by downregulating β-arrestin and GRK2, Front. Pharmacol., 13, 10.3389/fphar.2022.996321 · DOI
- Qiao, 2021, Chronic adrenergic stress contributes to metabolic dysfunction and an exhausted phenotype in T cells in the tumor microenvironment, Cancer Immunol. Res., 9, 651, 10.1158/2326-6066.CIR-20-0445 · DOI · Paper page
- Wang, 2020, IL-23 and PSMA-targeted duo-CAR T cells in Prostate Cancer Eradication in a preclinical model, J. Transl. Med., 18, 23, 10.1186/s12967-019-02206-w · DOI
- Hansen, 2018, Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study, Ann. Oncol., 29, 1807, 10.1093/annonc/mdy232 · DOI · Paper page
- He, 2020, Co-expression of IL-7 improves NKG2D-based CAR T cell therapy on prostate cancer by enhancing the expansion and inhibiting the apoptosis and exhaustion, Cancers, 12, 1969, 10.3390/cancers12071969 · DOI
- Grytli, 2013, Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy, Prostate, 73, 250, 10.1002/pros.22564 · DOI
- Braadland, 2014, β-adrenergic receptor signaling in prostate cancer, Front. Oncol., 4, 375
- Gao, 2021, Suppression of 4.1 R enhances the potency of NKG2D-CAR T cells against pancreatic carcinoma via activating ERK signaling pathway, Oncogenesis, 10, 62, 10.1038/s41389-021-00353-8 · DOI
- Zhou, 2023, Co-expression of IL-4/IL-15-based inverted cytokine receptor in CAR-T cells overcomes IL-4 signaling in immunosuppressive pancreatic tumor microenvironment, Biomed. Pharmacother., 168, 10.1016/j.biopha.2023.115740 · DOI
- Amaro, 2020, β-adrenoceptor activation in breast mcf-10a cells induces a pattern of catecholamine production similar to that of tumorigenic mcf-7 cells, Int. J. Mol. Sci., 21, 7968, 10.3390/ijms21217968 · DOI
- Zhao, 2019, The killing effect of novel bi-specific Trop2/PD-L1 CAR-T cell targeted gastric cancer, Am. J. Cancer Res., 9, 1846
- Guo, 2018, Phase I study of chimeric antigen receptor–modified T cells in patients with EGFR-positive advanced biliary tract cancers, Clin. Cancer Res., 24, 1277, 10.1158/1078-0432.CCR-17-0432 · DOI · Paper page
- Cruz-Guilloty, 2009, Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs, J. Exp. Med., 206, 51, 10.1084/jem.20081242 · DOI · Paper page
- Geng, 2023, Norepinephrine inhibits CD8+ T-cell infiltration and function, inducing anti-PD-1 mAb resistance in lung adenocarcinoma, Br. J. Cancer, 128, 1223, 10.1038/s41416-022-02132-7 · DOI
- Gu, 2000, Apoptotic signaling through the β-adrenergic receptor: a new Gs effector pathway, J. Biol. Chem., 275, 20726, 10.1074/jbc.M000152200 · DOI
- Liu, 2017, NF-κB signaling in inflammation, Signal Transduct. Targeted Ther., 2, 17023, 10.1038/sigtrans.2017.23 · DOI · Paper page
- Paixão, 2022, Modeling patient-specific CAR-T cell dynamics: Multiphasic kinetics via phenotypic differentiation, Cancers, 14, 5576, 10.3390/cancers14225576 · DOI
- Gardner, 2017, Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults, Blood, 129, 3322, 10.1182/blood-2017-02-769208 · DOI · Paper page
- Poorebrahim, 2021, Counteracting CAR T cell dysfunction, Oncogene, 40, 421, 10.1038/s41388-020-01501-x · DOI · Paper page
- Mueller, 2017, Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia. Blood, Am. J. Hematol., 130, 2317
- Eng, 2015, Housing temperature-induced stress drives therapeutic resistance in murine tumour models through β2-adrenergic receptor activation, Nat. Commun., 6, 6426, 10.1038/ncomms7426 · DOI
- Wang, 2019, Beta-adrenergic signaling in tumor immunology and immunotherapy, Crit. Rev. Immunol., 39, 93, 10.1615/CritRevImmunol.2019031188 · DOI
- Yang, 2023, Leveraging β-Adrenergic Receptor Signaling Blockade for Improved Cancer Immunotherapy Through Biomimetic Nanovaccine, Small, 19
- Brown, 2009, Hypoxia inducible factor (HIF)-2α is required for the development of the catecholaminergic phenotype of sympathoadrenal cells, J. Neurochem., 110, 622, 10.1111/j.1471-4159.2009.06153.x · DOI
- Bechmann, 2019, Impact of extrinsic and intrinsic hypoxia on catecholamine biosynthesis in absence or presence of HIF2α in pheochromocytoma cells, Cancers, 11, 594, 10.3390/cancers11050594 · DOI
- Estrada, 2022, Adrenergic signaling controls early transcriptional programs during CD8+ T cell responses to viral infection, PLoS One, 8
- Kalinichenko, 1999, Norepinephrine-mediated inhibition of antitumor cytotoxic T lymphocyte generation involves a β-adrenergic receptor mechanism and decreased TNF-α gene expression, J. Immunol., 163, 2492, 10.4049/jimmunol.163.5.2492 · DOI
- Geltink, 2018, Unraveling the complex interplay between T cell metabolism and function, Annu. Rev. Immunol., 36, 461, 10.1146/annurev-immunol-042617-053019 · DOI · Paper page
- Dorneles, 2020, New insights about regulatory T cells distribution and function with exercise: the role of immunometabolism, Curr. Pharm. Des., 26, 979, 10.2174/1381612826666200305125210 · DOI
- Ruiz-Medina, 2018, Isoproterenol-induced beta-2 adrenergic receptor activation negatively regulates interleukin-2 signaling, Biochem. J., 475, 2907, 10.1042/BCJ20180503 · DOI
- Bartik, 1993, Modulation of T cell proliferation by stimulation of the β-adrenergic receptor: lack of correlation between inhibition of T cell proliferation and cAMP accumulation, Cell. Immunol., 148, 408, 10.1006/cimm.1993.1122 · DOI
- Yan, 2000, β-Adrenergic receptor/cAMP-mediated signaling and apoptosis of S49 lymphoma cells, Am. J. Physiol. Cell Physiol., 279, C1665, 10.1152/ajpcell.2000.279.5.C1665 · DOI
- Prabhu, 2003, β-Adrenergic receptor blockade modulates Bcl-XS expression and reduces apoptosis in failing myocardium, J. Mol. Cell. Cardiol., 35, 483, 10.1016/S0022-2828(03)00052-X · DOI
- Mu, 2018, Metformin inhibits proliferation and cytotoxicity and induces apoptosis via AMPK pathway in CD19-chimeric antigen receptor-modified T cells, Onco. Targets Ther., 11, 1767, 10.2147/OTT.S154853 · DOI
- Liao, 2020, Propranolol suppresses the growth of colorectal cancer through simultaneously activating autologous CD8+ T cells and inhibiting tumor AKT/MAPK pathway, Clin. Pharmacol. Ther., 108, 606, 10.1002/cpt.1894 · DOI
- Chen, 2019, Mandated Cool Housing Temperature and Adrenergic Stress reduce the efficacy of radiation and mask the “Abscopal Effect” in mouse models of cancer, J. Immun., 202, 136.27, 10.4049/jimmunol.202.Supp.136.27 · doi:10.4049/jimmunol.202.supp.136.27
- Zhou, 2022, Sertraline inhibits stress-induced tumor growth through regulating CD8+ T cell-mediated anti-tumor immunity, Anticancer. Drugs, 33, 935, 10.1097/CAD.0000000000001383 · DOI
- Daher, 2018, Blockade of β-adrenergic receptor signaling improves cancer vaccine efficacy through its effect on naive CD8+ T-cell priming, Cancer Immunol. Res., 7, 1849, 10.1158/2326-6066.CIR-18-0833 · DOI
- Chen, 2020, Adrenergic stress constrains the development of anti-tumor immunity and abscopal responses following local radiation, Nat. Commun., 11, 1821, 10.1038/s41467-020-15676-0 · DOI
- Cherkassky, 2016, Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition, J. Clin. Invest., 126, 3130, 10.1172/JCI83092 · DOI · Paper page
- Chen, 2022, Chronic type I interferon signaling promotes lipid-peroxidation-driven terminal CD8+ T cell exhaustion and curtails anti-PD-1 efficacy, Cell Rep., 41, 10.1016/j.celrep.2022.111647 · DOI
- Loza, 2010, Regulation of T cells in airway disease by beta-agonist, Front. Biosci., 2, 969
Metadata
- Authors
- Ajmal, I., Farooq, M. A., Duan, Y., Yao, J., Gao, Y., Hui, X., Ge, Y., Chen, Y., Ren, Y., Du, B., & Jiang, W.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2024-10
- Volume
- 32
- Issue
- 10
- Pages
- 3539-3557
- ISSN
- 1525-0016
- Cited by
- 37
- References
- 1
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 366 d)
- Funders
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intrinsic ADRB2 inhibition improves CAR-T cell therapy efficacy against prostate cancer. https://app.cochat.ai/papers/10.1016/j.ymthe.2024.08.028
- The paper
- Ajmal, I., Farooq, M. A., Duan, Y., Yao, J., Gao, Y., Hui, X., Ge, Y., Chen, Y., Ren, Y., Du, B., & Jiang, W. (2024). Intrinsic ADRB2 inhibition improves CAR-T cell therapy efficacy against prostate cancer. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2024.08.028
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.